VASCUTEK, a TERUMO Company

VASCUTEK, a TERUMO Company is a world leader in the design and manufacture of products that address the needs of vascular and cardiovascular clinicians throughout the world.

For over 30 years, Vascutek has applied advanced and innovative technologies to develop a wide portfolio of products which include a AAA stent graft system and an extensive range of sealed woven and knitted polyester grafts for peripheral, abdominal and cardiothoracic surgery. Our range of products also feature ePTFE grafts, heart valves and conduits.

VASCUTEK, a TERUMO Company is a world leader in the design and manufacture of products that address the needs of vascular and cardiovascular clinicians throughout the world.

For 30 years, Vascutek has applied advanced and innovative technologies to develop a wide portfolio of products which include an extensive range of sealed woven and knitted polyester grafts for peripheral, abdominal and cardiothoracic surgery.

These technologies led to the development of Anaconda™, featuring BluGlide™, the new generation of AAA stent graft systems. It is the first repositionable device that also demonstrates exceptional flexibility.

Our range of products also feature ePTFE grafts and proven porcine heart valves.

1979 – Research and Development

Three groups worked together to develop a new vascular graft

1982 – Vascutek Ltd Founded

• Vascutek develop unique knitting machines capable of knitting to 60 needles per inch
• Triaxial™ and VP1200KTM grafts launched

1983 – Development of our Gelatin Sealant Begins

Vascutek's unique modified gelatin sealant:

• Removal in 14 days by simple hydrolysis
• No enzymatic mechanism required
• Antibiotic bonding option applies to all Vascutek sealed grafts
• Now 37 publications to support this clinical application
• CE Approval for the Rifampicin Bonding Process awarded in 2001

1992 – First Gelweave™ Grafts Produced

• GelweaveTM - a new design of zero porosity twill woven prosthesis

1999 – First ePTFE Grafts Launched

• Gelatin sealed Ultrathin ePTFE
• Gelatin sealed Tapered ePTFE
• ePTFE with unique ePTFE support
• Unsealed Ultrathin ePTFE

Gelatin sealed Ultrathin ePTFE		Gelatin sealed Tapered ePTFE
ePTFE with unique ePTFE support		Unsealed Ultrathin ePTFE

2001 – Gelweave Valsalva™ Launched

Gelweave Valsalva™

• A unique woven graft designed to closely match natural aortic root anatomy
• Patent protected
• FDA 510(K) received June 2002
• Mimics stretch response of the sinuses of Valsalva
• Reduces tension on coronary anastomoses
• Minimises leaflet damage
• Assists leaflet closure

2002 – Vascutek is Proud to Become Part of Terumo

2005 – Rapidax™

Rapidax™

• Access within 24 hours
• Rapid haemostasis following needle withdrawal
• Effectively no suture hole bleeding or "sweating"
• Antibiotic Bonding Option

2005 – Anaconda™

Anaconda™ AAA Stent Graft Receives CE Mark approval

2006 - BioValsalva™ The Biological Bentall

• Unique porcine aortic valved conduit
• Innovative self-sealing trilaminate graft material
• Pre-sewn device reduces procedure complexity and prevents valve-to-graft mismatch
• Closely matches aortic root anatomy
• Reduces patient risk - potential for reduced bypass, cross-clamp and procedural time
• Enables treatment of vulnerable patient groups

2007 – Koehler Medical joins Vascutek

Stented Aortic

• Single piece tissue component ensures correct anatomical valve shape
• Unique fresh mounting minimises bending stresses on the valve

Stentless Aortic

• Single piece design preserves the natural anatomy and optimises valve function
• The proven valve demonstrates "...very low transvascular gradients, good flow characteristics and low regurgitation rates"

Stented Aortic

Stentless Aortic

2009 - Queen's Award for Enterprise: Innovation

Vascutek receives its 7th Queen's Award for Enterprise in the Innovation category in recognition of BioValsalva™.

This prestigious award is granted each year by the Queen to a small number of British companies in recognition of achievements in specific areas – Innovation, International Trade and Sustainable Development.

Previously awarded in:

• 1988
• 1990
• 1993
• 1998
• 2008

2009 - Cobrahood™

ePTFE Vascular Prosthesis with Flared Outflow

• Thin for excellent handling
• Double layer wrap for added strength
• Fully customisable hood

2009 – BluGlide™

• Low friction hydrophilic coating significantly smoothes the passage of the delivery sheath through the arteries
• Kink resistant sheath with graduated stiffness provides
  
  • Controlled delivery
  • Excellent manoeuvrability for varying patient anatomies
• Highly radiopaque sheath tip marker for accurate deployment

Vascutek has always adopted a zero tolerance approach to unethical behaviour. We operate in an environment involving both ethical and legal responsibilities that extend not just to our employees, but to our customers, healthcare professionals, and other organisations with which we do business. The directors, officers, employees, consultants, representatives and agents of Vascutek are required to behave in an ethical manner at all times, and to comply with all laws, regulations, policies and procedures that affect their positions.

Download the Vascuteks Ethics Statemnet here.